Code | 02080 | ||||||||||
MA number | 41/0875/10-S | ||||||||||
Product Form: | tbl plg 90x35 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 41 - CARDIACA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 25.11.2010 |
Dokument: | Trimetazidin-DemlGroup PR 35mg_vhs.doc |
Dokument: | DHPC Trimetazidin - DG 12_ 11_ 2012.pdf |
SPC: | SPC_Trimetazidin TEVA PR 35 mg_tbl plg_11_2019.docx |
PIL: | PIL_Trimetazidin TEVA PR 35 mg_tbl plg_11_2019.docx |
Safety feature | Yes |
Data update: | 11.11.2019 |